GGrantIndex
Sort

34,240 grants matching atherosclerosis

Tyrosine phosphorylation of endothelial nitric oxide synthase

$367,500
David J Fulton · Augusta University · R01 · FY2008 · HL

Tyrosine phosphorylation of endothelial nitric oxide synthase

$367,500
David J Fulton · Augusta University · R01 · FY2009 · HL

MMP9 AND AORTIC ANEURYSM: DEVELOPING A MODEL

$367,500
Northwestern University · R01 · FY2002 · HL

Tyrosine phosphorylation of endothelial nitric oxide synthase

$367,500
David J Fulton · Augusta University · R01 · FY2010 · HL

Inhibiting Periodontitis by Targeting Cathepsin K and Attenuating TLR Signaling

$367,500
Yi-Ping Li · University Of Alabama At Birmingham · R01 · FY2016 · DE

Vascular Effects of Homocysteine in Humans

$367,500
University Of Iowa · R01 · FY2002 · HL

Inhibiting Periodontitis by Targeting Cathepsin K and Attenuating TLR Signaling

$367,500
Yi-Ping Li · University Of Alabama At Birmingham · R01 · FY2015 · DE

MMP9 AND AORTIC ANEURYSM: DEVELOPING A MOUSE MODEL

$367,500
Northwestern University · R01 · FY2001 · HL

Molecular basis of inflammation in retina, and novel strategies for limiting it

$367,500
Pamela M Martin · Augusta University · R01 · FY2015 · EY

Splenic Marginal Zone Macrophages in Chronic Ischemic Heart Failure

$367,500
Sumanth D Prabhu · University Of Alabama At Birmingham · R01 · FY2016 · HL

Plasmalogen-derived bioactive lipids in atherosclerosis

$367,500
David A. Ford · Saint Louis University · R01 · FY2014 · HL

Pin1 prolyl isomerase regulates endothelial nitric oxide synthase

$367,500
Richard C Venema · Augusta University · R01 · FY2014 · HL

Eicosanoids and Endothelial Cell Dysfunction

$367,500
Gadiparthi N Rao · University Of Tennessee Health Sci Ctr · R01 · FY2014 · HL

MMP9 AND AORTIC ANEURYSM: DEVELOPING A MOUSE MODEL

$367,500
Northwestern University · R01 · FY2000 · HL

Splenic Marginal Zone Macrophages in Chronic Ischemic Heart Failure

$367,500
Sumanth D Prabhu · University Of Alabama At Birmingham · R01 · FY2015 · HL

VASCULAR ANTI-INFLAMMATORY ACTIONS OF HSP90 INHIBITORS

$367,500
John D. Catravas · Augusta University · R01 · FY2011 · HL

VASCULAR ANTI-INFLAMMATORY ACTIONS OF HSP90 INHIBITORS

$367,500
John D. Catravas · Augusta University · R01 · FY2010 · HL

Mast Cell-Induced Inflammation in Vascular Disease

$367,500
Kottarappat N Dileepan · University Of Kansas Medical Center · R01 · FY2006 · HL

GOLPH3 in vascular smooth muscle cell biology and vascular disease

$367,500
Chunxiang Zhang · University Of Alabama At Birmingham · R01 · FY2017 · HL

GOLPH3 in vascular smooth muscle cell biology and vascular disease

$367,500
Chunxiang Zhang · University Of Alabama At Birmingham · R01 · FY2018 · HL

Molecular regulation of vascular calcification in atherosclerosis

$367,500
Yabing Chen · University Of Alabama At Birmingham · R01 · FY2018 · HL

GOLPH3 in vascular smooth muscle cell biology and vascular disease

$367,500
Gangjian Qin · University Of Alabama At Birmingham · R01 · FY2019 · HL

Role of Hippo-YAP Pathway in Smooth Muscle Phenotypic Modulation

$367,500
Jiliang Zhou · Augusta University · R01 · FY2014 · HL

Tyrosine phosphorylation of endothelial nitric oxide synthase

$367,500
David J Fulton · Augusta University · R01 · FY2011 · HL

Control of Sterol and Lipoprotein Homeostasis by miRNA

$367,500
Angel Baldan · Saint Louis University · R01 · FY2014 · HL